Leo Hung

Leo Hung is a seasoned finance professional with a focus on biotechnology. Currently serving as a panelist for the HKU Technology Transfer Office, Leo provides insights on funding applications for biotechnology projects. Previously, Leo held senior roles at various financial institutions, including Director at CITIC Securities and Head of ECM at Changjiang Securities, where they facilitated IPOs and institutional placements. With a background in research through their time at The Ohio State University and experience in managing clinical trials at PharmaEssentia, Leo combines analytical skills with a robust understanding of the financial and biotech industries.